Literature DB >> 20436492

Oncolytic viruses: now interviewing for the all-star game.

Richard Vile1.   

Abstract

Mesh：

Year:  2010        PMID： 20436492      PMCID： PMC2890096          DOI： 10.1038/mt.2010.60

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  11 in total

1.  Oncolytic viruses: time to compare, contrast, and combine? 5th international meeting on replicating oncolytic virus therapeutics. Banff, Alberta, Canada, 18-22 March 2009.

Authors:  Hardev Pandha; Alan Melcher; Kevin Harrington; Richard Vile
Journal:  Mol Ther       Date:  2009-06       Impact factor: 11.454

2.  Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.

Authors:  J A McCart; J M Ward; J Lee; Y Hu; H R Alexander; S K Libutti; B Moss; D L Bartlett
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

3.  Synergistic interaction between oncolytic viruses augments tumor killing.

Authors:  Fabrice Le Boeuf; Jean-Simon Diallo; J Andrea McCart; Steve Thorne; Theresa Falls; Marianne Stanford; Femina Kanji; Rebecca Auer; Christopher W Brown; Brian D Lichty; Kelley Parato; Harold Atkins; David Kirn; John C Bell
Journal:  Mol Ther       Date:  2010-03-16       Impact factor: 11.454

4.  Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.

Authors:  D F Stojdl; B Lichty; S Knowles; R Marius; H Atkins; N Sonenberg; J C Bell
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

Review 5.  The interferon system and vaccinia virus evasion mechanisms.

Authors:  Beatriz Perdiguero; Mariano Esteban
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

6.  Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling.

Authors:  O R Colamonici; P Domanski; S M Sweitzer; A Larner; R M Buller
Journal:  J Biol Chem       Date:  1995-07-07       Impact factor: 5.157

7.  The p14 FAST protein of reptilian reovirus increases vesicular stomatitis virus neuropathogenesis.

Authors:  Christopher W Brown; Kyle B Stephenson; Stephen Hanson; Michael Kucharczyk; Roy Duncan; John C Bell; Brian D Lichty
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

Review 8.  Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers.

Authors:  Herbert J Zeh; David L Bartlett
Journal:  Cancer Gene Ther       Date:  2002-12       Impact factor: 5.987

Review 9.  Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.

Authors:  Roberto Cattaneo; Tanner Miest; Elena V Shashkova; Michael A Barry
Journal:  Nat Rev Microbiol       Date:  2008-07       Impact factor: 60.633

10.  VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

Authors:  David F Stojdl; Brian D Lichty; Benjamin R tenOever; Jennifer M Paterson; Anthony T Power; Shane Knowles; Ricardo Marius; Jennifer Reynard; Laurent Poliquin; Harold Atkins; Earl G Brown; Russell K Durbin; Joan E Durbin; John Hiscott; John C Bell
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.